vs

Side-by-side financial comparison of AMC Networks Inc. (AMCX) and Five9, Inc. (FIVN). Click either name above to swap in a different company.

AMC Networks Inc. is the larger business by last-quarter revenue ($594.8M vs $300.3M, roughly 2.0× Five9, Inc.). On growth, Five9, Inc. posted the faster year-over-year revenue change (7.8% vs -0.8%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $40.4M). Over the past eight quarters, Five9, Inc.'s revenue compounded faster (10.3% CAGR vs -0.1%).

AMC Networks Inc. is an American independent mass media and entertainment corporation headquartered in 11 Penn Plaza, New York City. The company owns and operates the eponymous cable channel, BBC America, IFC, Sundance TV, and We TV. It also owns the art house movie theater IFC Center in New York City; the independent film companies Independent Film Company and RLJE Films, the anime licensor Sentai Filmworks, the premium subscription streaming services AMC+, IFC Films Unlimited, Acorn TV, All...

Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.

AMCX vs FIVN — Head-to-Head

Bigger by revenue
AMCX
AMCX
2.0× larger
AMCX
$594.8M
$300.3M
FIVN
Growing faster (revenue YoY)
FIVN
FIVN
+8.5% gap
FIVN
7.8%
-0.8%
AMCX
More free cash flow
FIVN
FIVN
$36.9M more FCF
FIVN
$77.3M
$40.4M
AMCX
Faster 2-yr revenue CAGR
FIVN
FIVN
Annualised
FIVN
10.3%
-0.1%
AMCX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMCX
AMCX
FIVN
FIVN
Revenue
$594.8M
$300.3M
Net Profit
$-55.5M
Gross Margin
49.7%
55.4%
Operating Margin
-8.6%
6.6%
Net Margin
-9.3%
Revenue YoY
-0.8%
7.8%
Net Profit YoY
80.5%
EPS (diluted)
$-0.97
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMCX
AMCX
FIVN
FIVN
Q4 25
$594.8M
$300.3M
Q3 25
$561.7M
$285.8M
Q2 25
$600.0M
$283.3M
Q1 25
$555.2M
$279.7M
Q4 24
$599.3M
$278.7M
Q3 24
$599.6M
$264.2M
Q2 24
$625.9M
$252.1M
Q1 24
$596.5M
$247.0M
Net Profit
AMCX
AMCX
FIVN
FIVN
Q4 25
$-55.5M
Q3 25
$76.5M
$18.0M
Q2 25
$50.3M
$1.2M
Q1 25
$18.0M
$576.0K
Q4 24
$-284.5M
Q3 24
$41.4M
$-4.5M
Q2 24
$-29.2M
$-12.8M
Q1 24
$45.8M
$-7.1M
Gross Margin
AMCX
AMCX
FIVN
FIVN
Q4 25
49.7%
55.4%
Q3 25
48.2%
55.0%
Q2 25
52.7%
54.9%
Q1 25
51.8%
55.0%
Q4 24
51.2%
56.0%
Q3 24
52.0%
53.8%
Q2 24
55.2%
53.0%
Q1 24
54.5%
53.6%
Operating Margin
AMCX
AMCX
FIVN
FIVN
Q4 25
-8.6%
6.6%
Q3 25
9.9%
5.6%
Q2 25
10.7%
-0.6%
Q1 25
11.6%
-1.9%
Q4 24
-42.4%
1.5%
Q3 24
15.6%
-5.8%
Q2 24
1.7%
-7.7%
Q1 24
18.5%
-8.4%
Net Margin
AMCX
AMCX
FIVN
FIVN
Q4 25
-9.3%
Q3 25
13.6%
6.3%
Q2 25
8.4%
0.4%
Q1 25
3.3%
0.2%
Q4 24
-47.5%
Q3 24
6.9%
-1.7%
Q2 24
-4.7%
-5.1%
Q1 24
7.7%
-2.9%
EPS (diluted)
AMCX
AMCX
FIVN
FIVN
Q4 25
$-0.97
$0.22
Q3 25
$1.38
$0.21
Q2 25
$0.91
$0.01
Q1 25
$0.34
$0.01
Q4 24
$-6.23
$0.16
Q3 24
$0.76
$-0.06
Q2 24
$-0.66
$-0.17
Q1 24
$1.03
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMCX
AMCX
FIVN
FIVN
Cash + ST InvestmentsLiquidity on hand
$502.4M
$232.1M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$981.9M
$785.8M
Total Assets
$3.9B
$1.8B
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMCX
AMCX
FIVN
FIVN
Q4 25
$502.4M
$232.1M
Q3 25
$716.8M
$193.4M
Q2 25
$866.4M
$205.5M
Q1 25
$870.2M
$370.3M
Q4 24
$784.6M
$362.5M
Q3 24
$816.4M
$291.0M
Q2 24
$802.6M
$175.7M
Q1 24
$690.5M
$240.2M
Total Debt
AMCX
AMCX
FIVN
FIVN
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.4B
Q1 24
$2.3B
Stockholders' Equity
AMCX
AMCX
FIVN
FIVN
Q4 25
$981.9M
$785.8M
Q3 25
$1.1B
$775.3M
Q2 25
$971.7M
$717.4M
Q1 25
$888.8M
$664.3M
Q4 24
$855.6M
$622.2M
Q3 24
$1.1B
$565.6M
Q2 24
$1.1B
$525.9M
Q1 24
$1.1B
$483.6M
Total Assets
AMCX
AMCX
FIVN
FIVN
Q4 25
$3.9B
$1.8B
Q3 25
$4.2B
$1.8B
Q2 25
$4.4B
$1.7B
Q1 25
$4.3B
$2.1B
Q4 24
$4.4B
$2.1B
Q3 24
$4.8B
$2.0B
Q2 24
$4.9B
$1.9B
Q1 24
$4.9B
$1.9B
Debt / Equity
AMCX
AMCX
FIVN
FIVN
Q4 25
1.78×
Q3 25
1.82×
Q2 25
2.27×
Q1 25
2.62×
Q4 24
2.73×
Q3 24
2.10×
Q2 24
2.26×
Q1 24
2.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMCX
AMCX
FIVN
FIVN
Operating Cash FlowLast quarter
$49.2M
$83.6M
Free Cash FlowOCF − Capex
$40.4M
$77.3M
FCF MarginFCF / Revenue
6.8%
25.8%
Capex IntensityCapex / Revenue
1.5%
2.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$272.4M
$201.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMCX
AMCX
FIVN
FIVN
Q4 25
$49.2M
$83.6M
Q3 25
$44.8M
$59.2M
Q2 25
$102.8M
$35.1M
Q1 25
$108.8M
$48.4M
Q4 24
$58.1M
$49.8M
Q3 24
$62.2M
$41.1M
Q2 24
$104.4M
$19.9M
Q1 24
$150.9M
$32.4M
Free Cash Flow
AMCX
AMCX
FIVN
FIVN
Q4 25
$40.4M
$77.3M
Q3 25
$42.0M
$48.7M
Q2 25
$95.7M
$31.6M
Q1 25
$94.2M
$43.7M
Q4 24
$37.6M
$40.5M
Q3 24
$53.9M
$26.7M
Q2 24
$95.2M
$13.1M
Q1 24
$144.1M
$20.4M
FCF Margin
AMCX
AMCX
FIVN
FIVN
Q4 25
6.8%
25.8%
Q3 25
7.5%
17.0%
Q2 25
16.0%
11.1%
Q1 25
17.0%
15.6%
Q4 24
6.3%
14.5%
Q3 24
9.0%
10.1%
Q2 24
15.2%
5.2%
Q1 24
24.2%
8.3%
Capex Intensity
AMCX
AMCX
FIVN
FIVN
Q4 25
1.5%
2.1%
Q3 25
0.5%
3.7%
Q2 25
1.2%
1.2%
Q1 25
2.6%
1.7%
Q4 24
3.4%
3.3%
Q3 24
1.4%
5.4%
Q2 24
1.5%
2.7%
Q1 24
1.1%
4.8%
Cash Conversion
AMCX
AMCX
FIVN
FIVN
Q4 25
Q3 25
0.59×
3.29×
Q2 25
2.04×
30.38×
Q1 25
6.03×
84.00×
Q4 24
Q3 24
1.50×
Q2 24
Q1 24
3.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMCX
AMCX

Subscription And Circulation$314.8M53%
Advertising$124.9M21%
Other$79.1M13%
License$74.8M13%
Related Party$1.2M0%

FIVN
FIVN

Segment breakdown not available.

Related Comparisons